SlideShare a Scribd company logo
CELLULAR ASPECTS
Receptors
G-protein coupled receptors
 Ion Channel Receptors
Receptor-enzymes
Cytosolic-nuclear receptors
G-protein coupled receptors
G-protein coupled receptor: GPCR
Examples:
Adrenergic receptors
Muscarinic ACh receptors
GABAB receptors
Metabotropic Glutamate receptors
Dopamine receptors
Metabotropic Serotonin receptors
G-protein coupled receptor: GPCR
More examples—hormones:
Angiotensin receptor
Bradykinin receptor
Thrombin receptor
FSH receptor
LH receptor
TSH receptor
ACTH receptor
GPCR structure
A single subunit with
7 transmembrane segments
out
in
A depiction of how GPCRs activate signaling
Ligand + GPCR GPCR* GPCR* abg
a + bg
signaling
abg Heterotrimeric GTP-binding protein (G protein)
GPCR G-protein coupled receptor
signalin
g
Another depiction of how GPCRs activate signaling
Heterotrimeric GTP-binding proteins cycle between
GTP- and GDP-bound state
Binding of ligand to G-protein coupled receptor facilitates
exchange of GTP for GDP, a and bg dissociate
a
b g
GDP
a b g
GTP
INACTIVE ACTIVE
Heterotrimeric G proteins
•Activated by binding of ligand to 7-transmembrane receptor
(G-protein coupled receptor)
•Ligand binding causes dissociation of a and bg subunits
•Dissociation allows GDP to exchange for GTP
•GTP binding causes conformational change, a subunit can
now interact with effector (e.g. AC)
•GTP is hydrolyzed to GDP, a subunit dissociates from effector
•Signal is terminated
Adenylate cyclase
Membrane protein
makes cAMP from ATP
ATP cAMP
Three major families of G-proteins
Gs couples to Adenylate Cyclase
stimulates AC activity
increases cAMP
activates Protein Kinase A
Gi couples to Adenylate Cyclase
inhibits AC activity
decreases cAMP
inhibits Protein Kinase A
Gq couples to Phospholipase C
increases diacylgyclerol
(DAG)
increases IP3
increases intracellular Ca2+
Gs
Gi
Gq
b-adrenergic receptor
ACTH receptor
FSH receptor
a2-adrenergic receptor
M2 muscarinic receptor
a1-adrenergic receptor
M1, M3 muscarinic receptors
Angiotensin receptor
cAMP
PKA activity
cAMP
PKA activity
PLC activity
DAG, IP3
Ca2+
PKC activity
G-protein Receptor examples Signaling pathway
cAMP-dependent stimulation of glucose liberation from glycogen
bAR
a
b g
GTP
AC
PKA
cAMP-dependent stimulation of cardiac muscle contraction
Ca2+
Ca2+
Ryanodine
Receptor
Sarcoplasmic reticulum
bAR = b-adrenergic receptor
cAMP is constantly inactivated by
phosphodiesterase
(active) (inactive)
Theophylline blocks the phosphodiesterase
Phospholipase C activation produces Diacylglycerol and IP3
PI 4,5 biphosphate (PIP2)
Plasma membrane lipid
plasma
membrane
Diacylglycerol
(DAG)
Inositol
1,4,5-triphosphate
(IP3)
cytosolic messenger
plasma membrane
a1-adrenergic receptors acting on vascular smooth muscle:
PLC IP3 Ca2+ calmodulin myosin light chain kinase
Myosin-P contraction
An example of the Gq signaling pathway
IP3 receptors: intracellular calcium channels
Controlling intracellular calcium levels
IP3
receptors
Ca2+
Intracellular
Ca2+
levels are
<< micromolar
Guanylate cyclase receptors
Guanylate Cyclase Receptors
Two Types:
1. Transmembrane Guanylate Cyclase Receptor
activated by peptide hormones
2. Soluble Guanylate Cyclase Receptor
activated by nitric oxide (NO)
target for anti-angina drugs
nitroglycerin
Atrial natriuretic peptide/factor ANP
Transmembrane Guanylate Cyclase Receptor
3 domains
Hormone binding
Transmembrane
Intracellular GC
domain with
catalytic activity
Single transmembrane receptor—similar to tyrosine kinase receptor
(binds ANP)
Signal transduction initiated by binding of ANP to
Transmembrane Guanylate Cyclase Receptor
1. Atrial natriuretic peptide binds to receptor, causes
conformational change
2. Guanylate cyclase is activated
3. cGMP is generated
4. cGMP dependent protein kinase is activated
5. proteins are phosphorylated
Smooth muscle cell contraction
cGMP-dependent protein kinase (PKG) phosphorylates many
proteins that modulate muscle contraction
Ca2+ channels
K+ channels
IP3 receptors
Myosin light chain
phosphatase
NPR-A ANP receptor
Soluble Guanylate Cyclase Receptor
(binds NO)
NO, a gas, can
cross cell membranes
Interacts with heme
group on GC
inside the cell
Mechanism of activation of Guanylate Cyclase by NO
NOS nitric oxide synthase
catalyzes oxidation of arginine to produce citrilline + NO gas
Signal transduction initiated by generation of NO
1. Nitric oxide synthase (NOS) is activated in generator cell
2. Nitric oxide is formed by NOS from arginine
3. Gaseous nitric oxide diffuses out of generator cell and
into target cell
4. Nitric oxide reacts with iron-containing heme group on
Guanylate Cyclase
5. Activated Guanylate Cyclase converts GTP to cyclic GMP
6. cGMP binds to cGMP-dependent protein kinase (PKG)
7. proteins are phosphorylated by PKG
Mechanisms by which NO induces relaxation of smooth muscle
Smooth muscle contractionNO activates guanylate cyclase
cGMP is produced
cGMP dependent protein
kinase is activated
Proteins that regulate
contraction are
phosphorylated
IP3 R
MLCP
Ca2+
chann Ch
K+
K+
chann
PKG
Mechanisms by which NO induces relaxation of smooth muscle
(review)
NO Guanylate Cyclase cGMP PKG
IP3R K+ Chann Ca2+ chann Myosin light chain phosphatase
CELL
GROWTH
P
ras
MAPK MAPK P
phosphorlyates multiple
target proteins
PDGF
dimerize &
phosphorylate each
other
Mechanism of signal transduction
Enzyme-linked Cell Surface Receptors
 Receptor Tyrosine kinases: phosphorylate specific tyrosines
 Tyrosine kinase associated receptors: associate with
intracellular proteins that have tyrosine kinase activity.
 Receptorlike tyrosine phosphatases: remove phosphate
group
 Receptor Serine/ Threonine kinases: phosphorylate specific
Serine/ Threonine
 Receptor guanylyl cyclases: directly catalyzes the production
of cGMP
 Histidine kinase associated receptors: kinase phoshorylates
itself on histidine and then transfers the phosphate to a second
intracellular signaling protein.
Receptor Tyrosine Kinases (RTKs)
 Intrinsic tyrosine kinase activity
 Soluble or membrane-bound ligands:
 Nerve growth factor, NGF
 Platelet-derived growth factor, PDGF
 Fibroblast growth factor, EGF
 Epidermal growt factor, EGF
 Insulin
 Downstream pathway activation:
 Ras-MAP kinase pathway
TYROSINE KINASE RECEPTORS
• these receptors traverse the membrane only once
• respond exclusively to protein stimuli
– cytokines
– mitogenic growth factors:
• platelet derived growth factor
• epidermal growth factor
 Functions include:
 Cell proliferation, differentiation
 Cell survival
 Cellular metabolism
 Some RTKs have been discovered in cancer research
 Her2, constitutively active form in breast cancer
 EGF-R overexpression in breast cancer
 Other RTKs have been uncovered in studies of
developmental mutations that block differentiation
Outline
 Activated RTKs transmit signal to Ras protein
 Ras transduces signal to downstream serine-threonine
kinases
 Ultimate activation of MAP kinase
 Activation of transcription factors
Ligand binding to RTKs
 Most RTKs are monomeric
 ligand binding to EC domain induces dimerization
 FGF binds to heparan sulfate enhancing its binding to
receptor: dimeric receptor-ligand complex
 Some ligands are dimeric: direct dimerization of receptors
 Insulin receptors occur naturally as a dimer
 Activation is due to the conformational change of the
receptor upon ligand binding
Substrate + ATP Substrate-P + ADP
Protein Tyrosine Kinase
Protein Tyrosine Phosphatase
(PTP)
Tyrosine Protein Phosphorylation
• Eukaryotic cells coordinate functions through environmental signals -
soluble factors, extracellular matrix, neighboring cells.
• Membrane receptors receive these cues and transduce signals into the
cell for appropriate response.
• Tyrosine kinase signalling is the major mechanism for receptor signal
transduction.
• Tyrosine protein phosphorylation is rare (1%) relative to
serine/threonine phosphorylation.
• TK pathways mediate cell growth, differentiation, host defense, and
metabolic regulation.
• Protein tyrosine phosphorylation is the net effect of protein tyrosine
kinases (TKs) and protein tyrosine phosphatases (PTPs).
Protein Tyrosine Kinases (TKs)
Receptor tyrosine kinases (RTK)
– insulin receptor
– EGF receptor
– PDGF receptor
– TrkA
Non-receptor tyrosine kinases (NRTK)
– c-Src
– Janus kinases (Jak)
– Csk (C-terminal src kinase)
– Focal adhesion kinase (FAK)
TABLE 15–4 Some Signaling Proteins That Act Via Receptor Tyrosine Kinases
SIGNALING LIGAND RECEPTORS SOME RESPONSES
Epidermal growth factor (EGF) EGF receptor stimulates proliferation of various cell
types
Insulin insulin receptor stimulates carbohydrate utilization and
protein synthesis
Insulin-like growth factors IGF receptor-1 stimulate cell growth and survival
(IGF-1 and IGF-2)
Nerve growth factor (NGF) Trk A stimulates survival and growth of some
neurons
Platelet-derived growth factors PDGF receptors stimulate survival, growth, and
proliferation of various cell types
Macrophage-colony-stimulating M-CSF receptor stimulates monocyte/macrophage
factor (M-CSF) proliferation and differentiation
Fibroblast growth factors FGF receptors stimulate proliferation of various cell (FGF-
(FGF1 to FGF-24) (FGF-R1–FGFR4) types; inhibit differentiation of some
precursor cells; inductive signals in
development
Vascular endothelial growth VEGF receptor stimulates angiogenesis
factor (VEGF)
Ephrins (A and B types) Eph receptors (A and B) stimulate angiogenesis; guide cell and
axon migration
Signaling from tyrosine kinase receptors
• Ligand induced dimerization
• Autophosphorylation
• Phosphorylation in the catalytic domain increase
the kinase activity
• Phosphorylation outside the catalytic domain
creates specific binding for other proteins.
• Autophosphorylated receptors bind to
signaling proteins that have SH2
(phosphotyrosine residues) domains
Consequences of receptor dimerization
 Kinase in one subunit P* one or more tyrosine residues
on the other
 Binding of ATP (insulin-R) or protein substrates (FGF-R)
 Enhanced kinase activity: P* of other sites on the receptor
 P*-tyrosine residues become docking sites for adapter
proteins
 Small proteins with SH2, PTB and SH3 domains, but
without intrinsic enzymatic or signaling activities
 Coupling activated RTKs to components of signaling
pathways such as Ras
Channel Families
 Voltage-gated
 Extracellular ligand-gated
 Intracellular ligand-gated
 Inward rectifier
 Intercellular
 Other
Typical Ion Channels with Known Structure:
K+ channel (KCSA)
Types of ion channels:
 Simple pores (GA, GAP junctions)
 Substrate gated channels (Nicotinic receptor)
 Voltage-gated channels (K-channels)
 Pumps (ATP-synthase, K+,Na+-ATPase)
What are the Biochemical Changes that Lead to
Channel Gating (Opening or Closing)?
Gating involves some type of conformational change in the
protein, but other than that there are few definitive
answers to the question.
However, there are several general proposed models for
gating.
Types of Biochemical Mechanisms that
Open and Close Channels
 Conformational change occurs in a discrete area of the
channel, leading to it opening.
 The entire channel changes conformation (e.g., electrical
synapses).
 Ball-and-chain – type mechanism.
 Nt or hormone binding causes the channel to open.
Types of Biochemical Mechanisms that
Open and Close Channels (Cont’d)
 Nt or hormone binding to receptor causes a 2nd messenger
to activate a protein kinase that phosphorylates a channel
and thus opens it.
 Changes in membrane potential.
 Membrane deformation (e.g., mechanical pressure).
 Selectivity by charge (i.e., positively lined pore allows
anions through; negatively lined pore allows cations
through).
Extracellular ligand-gated
 nicotinic ACh (muscle): a2bg (embryonic), a2b
(adult)
 nicotinic ACh (neuronal): a(2-10), b(2-4)
 glutamate: NMDA, kainate, AMPA
 P2X (ATP)
 5-HT3
 GABAA: a(1-6), b(1-4), g (1-4), , , (1-3)
 Glycine
Intracellular ligand-gated leukotriene C4-gated
Ca2+
 ryanodine receptor
Ca2+
 IP3-gated Ca2+
 IP4-gated Ca2+
 Ca2+-gated K+
 Ca2+-gated non-
selective cation
• Ca2+-gated Cl–
• cAMP cation
• cGMP cation
• cAMP chloride
• ATP Cl–
• volume-regulated Cl–
• arachidonic acid-
activated K+
• Na+-gated K+
Gated Ion Channels
 Another type of membrane transport
 Pores in the membrane that open and close in a
regulated manner and allow passage of ions
-“Dispose” of the gradients
 Passive transporters
-Ions flow from high to low concentration
-No energy is used
-If there is no gradient ions will not flow
Gated Ion Channels
 Small highly selective pores in the cell membrane
 Move ions or H2O
 Fast rate of transport 107 ions x s-1
 Transport is always down the gradient
 Cannot be coupled to an energy source
Ion channels are everywhere
 Channels are present in almost every cell
 Functions
-Transport of ions and H2O
-Regulation of electrical
potential across the
membrane
-Signaling
Gating mechanisms
 Two discrete states ;open (conducting) closed
(nonconducting)
 Some channels have also inactivated state (open but
nonconducting)
 Part of the channel structure or external particle
blocks otherwise open channel
What gates ion channels?
 Non gated - always open
 Gated
􀁺 Voltage across the cell membrane
􀁺 Ligand
􀁺 Mechanical stimulus, heat (thermal fluctuations)
Gating mechanisms
 Conformational changes in channel protein are
responsible for opening and closing of the pore
-3D conformational shape is determined by atomic,
electric, and hydrophobic forces
 Energy to switch the channel protein from one
conformational shape to another comes from the
gating source
Ligand gated channels
 Glutamate receptors
 Nicotinic acetylcholine receptor
 Vanilloid receptor family (TRPV)
= Neurotransmitter Ion Flow = Current
Ligand gated ion channels
 Gated by ligands present outside of the cell
 In fact they are receptors
 All of them are nonselective cation channels
 Mediate effects of neurotransmitters
Nuclear Receptors
1. Proteins interact with steroids and other
hormones that diffuse through the cell
membrane.
2. Form hormone-receptor complexes that function
as activators by binding to enhancers 
hormone response elements.
3. Sex hormones: estrogens and androgens;
glucocorticoids, cortisol, vitamin D  Ca2+
metabolism; thyroid hormone, retinoic acid 
developmental factors.
1. The majority of nuclear receptors bind to respective
enhancer elements and repress transcription.
- In the presence of hormone, they form R-H
complexes in the nucleus and function as activators
by binding to the same enhancers.
- Act as repressor or enhancer, depending on the
physiological signals.
- thus, the response element serves as either
enhancer or silencer.
Responses to hydrophobic hormones are mediated by
intracellular receptors
Transcription
Translation
Cytoplasm
Nucleus
Nuclear
envelope
Plasma
membrane Lipophilic hormone carried in
blood
Hormone binds intracellular
receptor inducing receptor
dimerization and activation
Complex is imported into
nucleus
Binds to “hormone response
element” to regulate gene
expression
Intracellular
receptor
Promoter Target gene“Hormone
response
element”
Target
cell
Lipophillic
Hormone
2. The glucocorticoid (nuclear) receptor is found in the
cytoplasm
Glucocorticoid Action
1. GR exists in an inactive form in the cytoplasm 
complexed with heat shock protein 90 (hsp90).
2. Glucocorticoid (G) diffuses across cell membrane
and enters cytoplasm
3. G binds to GR  changes conformation 
dissociates from hsp90
4.  exposes a nuclear localization signal (stretch of
aas) on GR.
5. G-GR (hormone-receptor complex, HR) enters
nucleus, dimerizes with another HR.
6. HR dimer binds to enhancer/hormone-response
element upstream of hormone activated gene.
7. Binding of HR dimer to enhancer  activates
transcription.
8. Most contain 2 zinc fingers (1) controls DNA
binding, (2) controls dimerization
Critical residues for discriminating
between GRE and ERE lie at the base
of the first finger
-GRE = glucocorticoid responsive element
/enhancer (sequence); ERE = estrogen
Specificity of DNA binding
dimerization
Cellular aspects of molecular pharmacology
Cellular aspects of molecular pharmacology

More Related Content

What's hot

Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.
MANISH mohan
 
G protein coupled receptor(gpcr)
G protein coupled receptor(gpcr)G protein coupled receptor(gpcr)
G protein coupled receptor(gpcr)
BHARAT KUMAR
 
G protein coupled receptors (Type II Hormone Signaling)
G protein coupled receptors (Type II Hormone Signaling)G protein coupled receptors (Type II Hormone Signaling)
G protein coupled receptors (Type II Hormone Signaling)
Pradeep Singh Narwat
 
G protein–coupled receptor
G protein–coupled receptorG protein–coupled receptor
G protein–coupled receptor
Harsha Chowdary
 
cell communications and cellular signalling systems vishnu
cell communications and cellular signalling systems   vishnucell communications and cellular signalling systems   vishnu
cell communications and cellular signalling systems vishnu
vishnu priya
 
Unit 2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)
Unit  2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)Unit  2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)
Unit 2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)
PHARMA IQ EDUCATION
 
Gpcr signalling
Gpcr signallingGpcr signalling
Gpcr signalling
gaganbrar4u
 
Heterotrimeric G-proteins
Heterotrimeric G-proteinsHeterotrimeric G-proteins
Heterotrimeric G-proteinsGulpreet Kaur
 
Seminar gpcr ppt
Seminar gpcr pptSeminar gpcr ppt
Seminar gpcr ppt
Manju Madhav
 
GPCR
GPCRGPCR
Cell signaling3
Cell signaling3Cell signaling3
Cell signaling3
Dr. Khuram Aziz
 
Mechanism of Drug Action
Mechanism of Drug ActionMechanism of Drug Action
Mechanism of Drug Action
Prashant Amale
 
G-protein receptors - BUGEMA UNIVERSITY
G-protein receptors - BUGEMA UNIVERSITY G-protein receptors - BUGEMA UNIVERSITY
G-protein receptors - BUGEMA UNIVERSITY
Muunda Mudenda
 
G protein signal
G protein signalG protein signal
G protein signal
Dr. Khuram Aziz
 
Molecular pharmacology of cell signling
Molecular pharmacology of cell signlingMolecular pharmacology of cell signling
Molecular pharmacology of cell signling
Mohanad Al-Bayati
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
Fardan Qadeer
 
G protein coupled receptors new
G protein coupled receptors newG protein coupled receptors new
G protein coupled receptors new
DrRenuYadav2
 
Medicinal chemistry Basics: Receptor
Medicinal chemistry Basics: ReceptorMedicinal chemistry Basics: Receptor
Medicinal chemistry Basics: Receptor
Rahul Patil PhD
 
G protein coupled receptors copy
G protein coupled receptors   copyG protein coupled receptors   copy
G protein coupled receptors copy
Sharanya Sunderamoorthy
 

What's hot (19)

Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.Receptor- ligand gated,enzyme linked, nuclear.
Receptor- ligand gated,enzyme linked, nuclear.
 
G protein coupled receptor(gpcr)
G protein coupled receptor(gpcr)G protein coupled receptor(gpcr)
G protein coupled receptor(gpcr)
 
G protein coupled receptors (Type II Hormone Signaling)
G protein coupled receptors (Type II Hormone Signaling)G protein coupled receptors (Type II Hormone Signaling)
G protein coupled receptors (Type II Hormone Signaling)
 
G protein–coupled receptor
G protein–coupled receptorG protein–coupled receptor
G protein–coupled receptor
 
cell communications and cellular signalling systems vishnu
cell communications and cellular signalling systems   vishnucell communications and cellular signalling systems   vishnu
cell communications and cellular signalling systems vishnu
 
Unit 2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)
Unit  2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)Unit  2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)
Unit 2 & 4 GPCRs WHOLE UNITS (GENERAL PHARMACOLOGY)
 
Gpcr signalling
Gpcr signallingGpcr signalling
Gpcr signalling
 
Heterotrimeric G-proteins
Heterotrimeric G-proteinsHeterotrimeric G-proteins
Heterotrimeric G-proteins
 
Seminar gpcr ppt
Seminar gpcr pptSeminar gpcr ppt
Seminar gpcr ppt
 
GPCR
GPCRGPCR
GPCR
 
Cell signaling3
Cell signaling3Cell signaling3
Cell signaling3
 
Mechanism of Drug Action
Mechanism of Drug ActionMechanism of Drug Action
Mechanism of Drug Action
 
G-protein receptors - BUGEMA UNIVERSITY
G-protein receptors - BUGEMA UNIVERSITY G-protein receptors - BUGEMA UNIVERSITY
G-protein receptors - BUGEMA UNIVERSITY
 
G protein signal
G protein signalG protein signal
G protein signal
 
Molecular pharmacology of cell signling
Molecular pharmacology of cell signlingMolecular pharmacology of cell signling
Molecular pharmacology of cell signling
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
 
G protein coupled receptors new
G protein coupled receptors newG protein coupled receptors new
G protein coupled receptors new
 
Medicinal chemistry Basics: Receptor
Medicinal chemistry Basics: ReceptorMedicinal chemistry Basics: Receptor
Medicinal chemistry Basics: Receptor
 
G protein coupled receptors copy
G protein coupled receptors   copyG protein coupled receptors   copy
G protein coupled receptors copy
 

Viewers also liked

Receptor tyrosine kinase
Receptor tyrosine kinaseReceptor tyrosine kinase
Receptor tyrosine kinase
Sobia
 
Rho GTPases as regulators of morphological neuroplasticity
Rho GTPases as regulators of morphological neuroplasticityRho GTPases as regulators of morphological neuroplasticity
Rho GTPases as regulators of morphological neuroplasticityFatih University
 
Tyrosine kinase ppt
Tyrosine kinase pptTyrosine kinase ppt
Tyrosine kinase ppt
Charan Ingole
 
Signal transduction
Signal transductionSignal transduction
Signal transduction
Dr.M.Prasad Naidu
 
Cell signalling
Cell signallingCell signalling
Cell signalling
DrTanviVerma
 
MECHANISM OF ACTION OF HORMONES
MECHANISM OF ACTION OF HORMONESMECHANISM OF ACTION OF HORMONES
MECHANISM OF ACTION OF HORMONES
YESANNA
 
Receptor Tyrosine Kinases
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinasesfondas vakalis
 
Enzyme linked receptors (1)
Enzyme linked receptors (1)Enzyme linked receptors (1)
Enzyme linked receptors (1)Sahar Musarrat
 

Viewers also liked (9)

Receptor tyrosine kinase
Receptor tyrosine kinaseReceptor tyrosine kinase
Receptor tyrosine kinase
 
Rho GTPases as regulators of morphological neuroplasticity
Rho GTPases as regulators of morphological neuroplasticityRho GTPases as regulators of morphological neuroplasticity
Rho GTPases as regulators of morphological neuroplasticity
 
Tyrosine kinase ppt
Tyrosine kinase pptTyrosine kinase ppt
Tyrosine kinase ppt
 
Signal transduction
Signal transductionSignal transduction
Signal transduction
 
Cell signalling
Cell signallingCell signalling
Cell signalling
 
MECHANISM OF ACTION OF HORMONES
MECHANISM OF ACTION OF HORMONESMECHANISM OF ACTION OF HORMONES
MECHANISM OF ACTION OF HORMONES
 
Hormone Metabolism
Hormone MetabolismHormone Metabolism
Hormone Metabolism
 
Receptor Tyrosine Kinases
Receptor Tyrosine KinasesReceptor Tyrosine Kinases
Receptor Tyrosine Kinases
 
Enzyme linked receptors (1)
Enzyme linked receptors (1)Enzyme linked receptors (1)
Enzyme linked receptors (1)
 

Similar to Cellular aspects of molecular pharmacology

Signaling.pptx
Signaling.pptxSignaling.pptx
Signaling.pptx
AnnIrene2
 
signal transduction
signal transductionsignal transduction
signal transduction
Koppala RVS Chaitanya
 
Signal Transduction Revised
Signal Transduction RevisedSignal Transduction Revised
Signal Transduction RevisedMD Specialclass
 
Cell Signaling
Cell SignalingCell Signaling
Cell SignalingEuplectes
 
Receptors
ReceptorsReceptors
Receptors
Raveena Chauhan
 
Drug transducing machinery
Drug transducing machineryDrug transducing machinery
Drug transducing machinery
SahilIndora
 
Mechanism of Hormone Action
Mechanism of Hormone ActionMechanism of Hormone Action
Mechanism of Hormone Action
Garry D. Lasaga
 
Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptDr. Khuram Aziz
 
Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptDr. Khuram Aziz
 
Protein phosphorylation, kinases and phosphatases
Protein phosphorylation, kinases and phosphatasesProtein phosphorylation, kinases and phosphatases
Protein phosphorylation, kinases and phosphatases
Jeju National University
 
SIGNAL TRANSDUCTION.pptx
SIGNAL TRANSDUCTION.pptxSIGNAL TRANSDUCTION.pptx
SIGNAL TRANSDUCTION.pptx
MMridhunaManoharan
 
Receptor
ReceptorReceptor
Receptor
Diksha Singh
 
G protien coupled receptor by yatendra singh
G  protien coupled receptor by yatendra singhG  protien coupled receptor by yatendra singh
G protien coupled receptor by yatendra singh
Yatendra Singh
 
cell cycle.pptx
cell cycle.pptxcell cycle.pptx
cell cycle.pptx
Dr.Shubham Patel
 
Cell signalling 2
Cell signalling   2Cell signalling   2
Cell signalling 2
Dr. Khuram Aziz
 
Hormone (1).pptx
Hormone (1).pptxHormone (1).pptx
Hormone (1).pptx
RezaAfrisham
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
Sumit Kumar
 
gproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdfgproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdf
bajosalimatou9
 

Similar to Cellular aspects of molecular pharmacology (20)

Signaling.pptx
Signaling.pptxSignaling.pptx
Signaling.pptx
 
Second Messenger Systems
Second Messenger SystemsSecond Messenger Systems
Second Messenger Systems
 
signal transduction
signal transductionsignal transduction
signal transduction
 
Signal Transduction Revised
Signal Transduction RevisedSignal Transduction Revised
Signal Transduction Revised
 
Cell Signaling
Cell SignalingCell Signaling
Cell Signaling
 
Receptors
ReceptorsReceptors
Receptors
 
Drug transducing machinery
Drug transducing machineryDrug transducing machinery
Drug transducing machinery
 
Mechanism of Hormone Action
Mechanism of Hormone ActionMechanism of Hormone Action
Mechanism of Hormone Action
 
Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.ppt
 
Receptor tyrosine kinases.ppt
Receptor tyrosine kinases.pptReceptor tyrosine kinases.ppt
Receptor tyrosine kinases.ppt
 
Protein phosphorylation, kinases and phosphatases
Protein phosphorylation, kinases and phosphatasesProtein phosphorylation, kinases and phosphatases
Protein phosphorylation, kinases and phosphatases
 
SIGNAL TRANSDUCTION.pptx
SIGNAL TRANSDUCTION.pptxSIGNAL TRANSDUCTION.pptx
SIGNAL TRANSDUCTION.pptx
 
Receptor
ReceptorReceptor
Receptor
 
Third messanger
Third messangerThird messanger
Third messanger
 
G protien coupled receptor by yatendra singh
G  protien coupled receptor by yatendra singhG  protien coupled receptor by yatendra singh
G protien coupled receptor by yatendra singh
 
cell cycle.pptx
cell cycle.pptxcell cycle.pptx
cell cycle.pptx
 
Cell signalling 2
Cell signalling   2Cell signalling   2
Cell signalling 2
 
Hormone (1).pptx
Hormone (1).pptxHormone (1).pptx
Hormone (1).pptx
 
G protein coupled receptor
G protein coupled receptorG protein coupled receptor
G protein coupled receptor
 
gproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdfgproteincoupledreceptor-170520064151 2.pdf
gproteincoupledreceptor-170520064151 2.pdf
 

More from Abhinav Sawhney

Obesity
ObesityObesity
Sulfonamides and trimethoprim
Sulfonamides and trimethoprimSulfonamides and trimethoprim
Sulfonamides and trimethoprimAbhinav Sawhney
 
Factors modifying drug effects
Factors modifying drug effectsFactors modifying drug effects
Factors modifying drug effectsAbhinav Sawhney
 

More from Abhinav Sawhney (9)

Obesity
ObesityObesity
Obesity
 
Contraceptions
ContraceptionsContraceptions
Contraceptions
 
Pharmacodynmics
PharmacodynmicsPharmacodynmics
Pharmacodynmics
 
Sulfonamides and trimethoprim
Sulfonamides and trimethoprimSulfonamides and trimethoprim
Sulfonamides and trimethoprim
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Erectile dysfunction
Erectile dysfunctionErectile dysfunction
Erectile dysfunction
 
Factors modifying drug effects
Factors modifying drug effectsFactors modifying drug effects
Factors modifying drug effects
 
Scrub typhus
Scrub typhusScrub typhus
Scrub typhus
 
Geriatrics
GeriatricsGeriatrics
Geriatrics
 

Recently uploaded

FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
Introduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - CybersecurityIntroduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - Cybersecurity
mikeeftimakis1
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
DanBrown980551
 
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Albert Hoitingh
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
Guy Korland
 
Welocme to ViralQR, your best QR code generator.
Welocme to ViralQR, your best QR code generator.Welocme to ViralQR, your best QR code generator.
Welocme to ViralQR, your best QR code generator.
ViralQR
 
By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024
Pierluigi Pugliese
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
Alison B. Lowndes
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Thierry Lestable
 
When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...
Elena Simperl
 
The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
Jemma Hussein Allen
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
Generative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionGenerative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to Production
Aggregage
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
Thijs Feryn
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
Alan Dix
 
Free Complete Python - A step towards Data Science
Free Complete Python - A step towards Data ScienceFree Complete Python - A step towards Data Science
Free Complete Python - A step towards Data Science
RinaMondal9
 

Recently uploaded (20)

FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
Introduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - CybersecurityIntroduction to CHERI technology - Cybersecurity
Introduction to CHERI technology - Cybersecurity
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...
 
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024
 
GraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge GraphGraphRAG is All You need? LLM & Knowledge Graph
GraphRAG is All You need? LLM & Knowledge Graph
 
Welocme to ViralQR, your best QR code generator.
Welocme to ViralQR, your best QR code generator.Welocme to ViralQR, your best QR code generator.
Welocme to ViralQR, your best QR code generator.
 
By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024By Design, not by Accident - Agile Venture Bolzano 2024
By Design, not by Accident - Agile Venture Bolzano 2024
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
 
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
Empowering NextGen Mobility via Large Action Model Infrastructure (LAMI): pav...
 
When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...When stars align: studies in data quality, knowledge graphs, and machine lear...
When stars align: studies in data quality, knowledge graphs, and machine lear...
 
The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
Generative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to ProductionGenerative AI Deep Dive: Advancing from Proof of Concept to Production
Generative AI Deep Dive: Advancing from Proof of Concept to Production
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
Accelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish CachingAccelerate your Kubernetes clusters with Varnish Caching
Accelerate your Kubernetes clusters with Varnish Caching
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
 
Free Complete Python - A step towards Data Science
Free Complete Python - A step towards Data ScienceFree Complete Python - A step towards Data Science
Free Complete Python - A step towards Data Science
 

Cellular aspects of molecular pharmacology

  • 2. Receptors G-protein coupled receptors  Ion Channel Receptors Receptor-enzymes Cytosolic-nuclear receptors
  • 4. G-protein coupled receptor: GPCR Examples: Adrenergic receptors Muscarinic ACh receptors GABAB receptors Metabotropic Glutamate receptors Dopamine receptors Metabotropic Serotonin receptors
  • 5. G-protein coupled receptor: GPCR More examples—hormones: Angiotensin receptor Bradykinin receptor Thrombin receptor FSH receptor LH receptor TSH receptor ACTH receptor
  • 6. GPCR structure A single subunit with 7 transmembrane segments out in
  • 7. A depiction of how GPCRs activate signaling
  • 8. Ligand + GPCR GPCR* GPCR* abg a + bg signaling abg Heterotrimeric GTP-binding protein (G protein) GPCR G-protein coupled receptor signalin g Another depiction of how GPCRs activate signaling
  • 9. Heterotrimeric GTP-binding proteins cycle between GTP- and GDP-bound state Binding of ligand to G-protein coupled receptor facilitates exchange of GTP for GDP, a and bg dissociate a b g GDP a b g GTP INACTIVE ACTIVE
  • 10. Heterotrimeric G proteins •Activated by binding of ligand to 7-transmembrane receptor (G-protein coupled receptor) •Ligand binding causes dissociation of a and bg subunits •Dissociation allows GDP to exchange for GTP •GTP binding causes conformational change, a subunit can now interact with effector (e.g. AC) •GTP is hydrolyzed to GDP, a subunit dissociates from effector •Signal is terminated
  • 12. Three major families of G-proteins Gs couples to Adenylate Cyclase stimulates AC activity increases cAMP activates Protein Kinase A Gi couples to Adenylate Cyclase inhibits AC activity decreases cAMP inhibits Protein Kinase A Gq couples to Phospholipase C increases diacylgyclerol (DAG) increases IP3 increases intracellular Ca2+
  • 13. Gs Gi Gq b-adrenergic receptor ACTH receptor FSH receptor a2-adrenergic receptor M2 muscarinic receptor a1-adrenergic receptor M1, M3 muscarinic receptors Angiotensin receptor cAMP PKA activity cAMP PKA activity PLC activity DAG, IP3 Ca2+ PKC activity G-protein Receptor examples Signaling pathway
  • 14. cAMP-dependent stimulation of glucose liberation from glycogen
  • 15. bAR a b g GTP AC PKA cAMP-dependent stimulation of cardiac muscle contraction Ca2+ Ca2+ Ryanodine Receptor Sarcoplasmic reticulum bAR = b-adrenergic receptor
  • 16. cAMP is constantly inactivated by phosphodiesterase (active) (inactive) Theophylline blocks the phosphodiesterase
  • 17. Phospholipase C activation produces Diacylglycerol and IP3 PI 4,5 biphosphate (PIP2) Plasma membrane lipid plasma membrane Diacylglycerol (DAG) Inositol 1,4,5-triphosphate (IP3) cytosolic messenger plasma membrane
  • 18. a1-adrenergic receptors acting on vascular smooth muscle: PLC IP3 Ca2+ calmodulin myosin light chain kinase Myosin-P contraction An example of the Gq signaling pathway
  • 19. IP3 receptors: intracellular calcium channels
  • 20. Controlling intracellular calcium levels IP3 receptors Ca2+ Intracellular Ca2+ levels are << micromolar
  • 22. Guanylate Cyclase Receptors Two Types: 1. Transmembrane Guanylate Cyclase Receptor activated by peptide hormones 2. Soluble Guanylate Cyclase Receptor activated by nitric oxide (NO) target for anti-angina drugs nitroglycerin Atrial natriuretic peptide/factor ANP
  • 23. Transmembrane Guanylate Cyclase Receptor 3 domains Hormone binding Transmembrane Intracellular GC domain with catalytic activity Single transmembrane receptor—similar to tyrosine kinase receptor (binds ANP)
  • 24. Signal transduction initiated by binding of ANP to Transmembrane Guanylate Cyclase Receptor 1. Atrial natriuretic peptide binds to receptor, causes conformational change 2. Guanylate cyclase is activated 3. cGMP is generated 4. cGMP dependent protein kinase is activated 5. proteins are phosphorylated
  • 25. Smooth muscle cell contraction cGMP-dependent protein kinase (PKG) phosphorylates many proteins that modulate muscle contraction Ca2+ channels K+ channels IP3 receptors Myosin light chain phosphatase NPR-A ANP receptor
  • 26. Soluble Guanylate Cyclase Receptor (binds NO) NO, a gas, can cross cell membranes Interacts with heme group on GC inside the cell
  • 27. Mechanism of activation of Guanylate Cyclase by NO NOS nitric oxide synthase catalyzes oxidation of arginine to produce citrilline + NO gas
  • 28. Signal transduction initiated by generation of NO 1. Nitric oxide synthase (NOS) is activated in generator cell 2. Nitric oxide is formed by NOS from arginine 3. Gaseous nitric oxide diffuses out of generator cell and into target cell 4. Nitric oxide reacts with iron-containing heme group on Guanylate Cyclase 5. Activated Guanylate Cyclase converts GTP to cyclic GMP 6. cGMP binds to cGMP-dependent protein kinase (PKG) 7. proteins are phosphorylated by PKG
  • 29. Mechanisms by which NO induces relaxation of smooth muscle Smooth muscle contractionNO activates guanylate cyclase cGMP is produced cGMP dependent protein kinase is activated Proteins that regulate contraction are phosphorylated IP3 R MLCP Ca2+ chann Ch K+ K+ chann PKG
  • 30. Mechanisms by which NO induces relaxation of smooth muscle (review) NO Guanylate Cyclase cGMP PKG IP3R K+ Chann Ca2+ chann Myosin light chain phosphatase
  • 31.
  • 32. CELL GROWTH P ras MAPK MAPK P phosphorlyates multiple target proteins PDGF dimerize & phosphorylate each other Mechanism of signal transduction
  • 33. Enzyme-linked Cell Surface Receptors  Receptor Tyrosine kinases: phosphorylate specific tyrosines  Tyrosine kinase associated receptors: associate with intracellular proteins that have tyrosine kinase activity.  Receptorlike tyrosine phosphatases: remove phosphate group  Receptor Serine/ Threonine kinases: phosphorylate specific Serine/ Threonine  Receptor guanylyl cyclases: directly catalyzes the production of cGMP  Histidine kinase associated receptors: kinase phoshorylates itself on histidine and then transfers the phosphate to a second intracellular signaling protein.
  • 34. Receptor Tyrosine Kinases (RTKs)  Intrinsic tyrosine kinase activity  Soluble or membrane-bound ligands:  Nerve growth factor, NGF  Platelet-derived growth factor, PDGF  Fibroblast growth factor, EGF  Epidermal growt factor, EGF  Insulin  Downstream pathway activation:  Ras-MAP kinase pathway
  • 35. TYROSINE KINASE RECEPTORS • these receptors traverse the membrane only once • respond exclusively to protein stimuli – cytokines – mitogenic growth factors: • platelet derived growth factor • epidermal growth factor
  • 36.  Functions include:  Cell proliferation, differentiation  Cell survival  Cellular metabolism  Some RTKs have been discovered in cancer research  Her2, constitutively active form in breast cancer  EGF-R overexpression in breast cancer  Other RTKs have been uncovered in studies of developmental mutations that block differentiation
  • 37. Outline  Activated RTKs transmit signal to Ras protein  Ras transduces signal to downstream serine-threonine kinases  Ultimate activation of MAP kinase  Activation of transcription factors
  • 38. Ligand binding to RTKs  Most RTKs are monomeric  ligand binding to EC domain induces dimerization  FGF binds to heparan sulfate enhancing its binding to receptor: dimeric receptor-ligand complex  Some ligands are dimeric: direct dimerization of receptors  Insulin receptors occur naturally as a dimer  Activation is due to the conformational change of the receptor upon ligand binding
  • 39. Substrate + ATP Substrate-P + ADP Protein Tyrosine Kinase Protein Tyrosine Phosphatase (PTP)
  • 40. Tyrosine Protein Phosphorylation • Eukaryotic cells coordinate functions through environmental signals - soluble factors, extracellular matrix, neighboring cells. • Membrane receptors receive these cues and transduce signals into the cell for appropriate response. • Tyrosine kinase signalling is the major mechanism for receptor signal transduction. • Tyrosine protein phosphorylation is rare (1%) relative to serine/threonine phosphorylation. • TK pathways mediate cell growth, differentiation, host defense, and metabolic regulation. • Protein tyrosine phosphorylation is the net effect of protein tyrosine kinases (TKs) and protein tyrosine phosphatases (PTPs).
  • 41. Protein Tyrosine Kinases (TKs) Receptor tyrosine kinases (RTK) – insulin receptor – EGF receptor – PDGF receptor – TrkA Non-receptor tyrosine kinases (NRTK) – c-Src – Janus kinases (Jak) – Csk (C-terminal src kinase) – Focal adhesion kinase (FAK)
  • 42. TABLE 15–4 Some Signaling Proteins That Act Via Receptor Tyrosine Kinases SIGNALING LIGAND RECEPTORS SOME RESPONSES Epidermal growth factor (EGF) EGF receptor stimulates proliferation of various cell types Insulin insulin receptor stimulates carbohydrate utilization and protein synthesis Insulin-like growth factors IGF receptor-1 stimulate cell growth and survival (IGF-1 and IGF-2) Nerve growth factor (NGF) Trk A stimulates survival and growth of some neurons Platelet-derived growth factors PDGF receptors stimulate survival, growth, and proliferation of various cell types Macrophage-colony-stimulating M-CSF receptor stimulates monocyte/macrophage factor (M-CSF) proliferation and differentiation Fibroblast growth factors FGF receptors stimulate proliferation of various cell (FGF- (FGF1 to FGF-24) (FGF-R1–FGFR4) types; inhibit differentiation of some precursor cells; inductive signals in development Vascular endothelial growth VEGF receptor stimulates angiogenesis factor (VEGF) Ephrins (A and B types) Eph receptors (A and B) stimulate angiogenesis; guide cell and axon migration
  • 43. Signaling from tyrosine kinase receptors • Ligand induced dimerization • Autophosphorylation • Phosphorylation in the catalytic domain increase the kinase activity • Phosphorylation outside the catalytic domain creates specific binding for other proteins. • Autophosphorylated receptors bind to signaling proteins that have SH2 (phosphotyrosine residues) domains
  • 44. Consequences of receptor dimerization  Kinase in one subunit P* one or more tyrosine residues on the other  Binding of ATP (insulin-R) or protein substrates (FGF-R)  Enhanced kinase activity: P* of other sites on the receptor  P*-tyrosine residues become docking sites for adapter proteins  Small proteins with SH2, PTB and SH3 domains, but without intrinsic enzymatic or signaling activities  Coupling activated RTKs to components of signaling pathways such as Ras
  • 45.
  • 46. Channel Families  Voltage-gated  Extracellular ligand-gated  Intracellular ligand-gated  Inward rectifier  Intercellular  Other
  • 47. Typical Ion Channels with Known Structure: K+ channel (KCSA) Types of ion channels:  Simple pores (GA, GAP junctions)  Substrate gated channels (Nicotinic receptor)  Voltage-gated channels (K-channels)  Pumps (ATP-synthase, K+,Na+-ATPase)
  • 48. What are the Biochemical Changes that Lead to Channel Gating (Opening or Closing)? Gating involves some type of conformational change in the protein, but other than that there are few definitive answers to the question. However, there are several general proposed models for gating.
  • 49. Types of Biochemical Mechanisms that Open and Close Channels  Conformational change occurs in a discrete area of the channel, leading to it opening.  The entire channel changes conformation (e.g., electrical synapses).  Ball-and-chain – type mechanism.  Nt or hormone binding causes the channel to open.
  • 50. Types of Biochemical Mechanisms that Open and Close Channels (Cont’d)  Nt or hormone binding to receptor causes a 2nd messenger to activate a protein kinase that phosphorylates a channel and thus opens it.  Changes in membrane potential.  Membrane deformation (e.g., mechanical pressure).  Selectivity by charge (i.e., positively lined pore allows anions through; negatively lined pore allows cations through).
  • 51. Extracellular ligand-gated  nicotinic ACh (muscle): a2bg (embryonic), a2b (adult)  nicotinic ACh (neuronal): a(2-10), b(2-4)  glutamate: NMDA, kainate, AMPA  P2X (ATP)  5-HT3  GABAA: a(1-6), b(1-4), g (1-4), , , (1-3)  Glycine
  • 52. Intracellular ligand-gated leukotriene C4-gated Ca2+  ryanodine receptor Ca2+  IP3-gated Ca2+  IP4-gated Ca2+  Ca2+-gated K+  Ca2+-gated non- selective cation • Ca2+-gated Cl– • cAMP cation • cGMP cation • cAMP chloride • ATP Cl– • volume-regulated Cl– • arachidonic acid- activated K+ • Na+-gated K+
  • 53. Gated Ion Channels  Another type of membrane transport  Pores in the membrane that open and close in a regulated manner and allow passage of ions -“Dispose” of the gradients  Passive transporters -Ions flow from high to low concentration -No energy is used -If there is no gradient ions will not flow
  • 54. Gated Ion Channels  Small highly selective pores in the cell membrane  Move ions or H2O  Fast rate of transport 107 ions x s-1  Transport is always down the gradient  Cannot be coupled to an energy source
  • 55. Ion channels are everywhere  Channels are present in almost every cell  Functions -Transport of ions and H2O -Regulation of electrical potential across the membrane -Signaling
  • 56. Gating mechanisms  Two discrete states ;open (conducting) closed (nonconducting)  Some channels have also inactivated state (open but nonconducting)  Part of the channel structure or external particle blocks otherwise open channel
  • 57.
  • 58. What gates ion channels?  Non gated - always open  Gated 􀁺 Voltage across the cell membrane 􀁺 Ligand 􀁺 Mechanical stimulus, heat (thermal fluctuations)
  • 59. Gating mechanisms  Conformational changes in channel protein are responsible for opening and closing of the pore -3D conformational shape is determined by atomic, electric, and hydrophobic forces  Energy to switch the channel protein from one conformational shape to another comes from the gating source
  • 60. Ligand gated channels  Glutamate receptors  Nicotinic acetylcholine receptor  Vanilloid receptor family (TRPV) = Neurotransmitter Ion Flow = Current
  • 61. Ligand gated ion channels  Gated by ligands present outside of the cell  In fact they are receptors  All of them are nonselective cation channels  Mediate effects of neurotransmitters
  • 62.
  • 63. Nuclear Receptors 1. Proteins interact with steroids and other hormones that diffuse through the cell membrane. 2. Form hormone-receptor complexes that function as activators by binding to enhancers  hormone response elements. 3. Sex hormones: estrogens and androgens; glucocorticoids, cortisol, vitamin D  Ca2+ metabolism; thyroid hormone, retinoic acid  developmental factors.
  • 64. 1. The majority of nuclear receptors bind to respective enhancer elements and repress transcription. - In the presence of hormone, they form R-H complexes in the nucleus and function as activators by binding to the same enhancers. - Act as repressor or enhancer, depending on the physiological signals. - thus, the response element serves as either enhancer or silencer.
  • 65. Responses to hydrophobic hormones are mediated by intracellular receptors Transcription Translation Cytoplasm Nucleus Nuclear envelope Plasma membrane Lipophilic hormone carried in blood Hormone binds intracellular receptor inducing receptor dimerization and activation Complex is imported into nucleus Binds to “hormone response element” to regulate gene expression Intracellular receptor Promoter Target gene“Hormone response element” Target cell Lipophillic Hormone
  • 66. 2. The glucocorticoid (nuclear) receptor is found in the cytoplasm
  • 67. Glucocorticoid Action 1. GR exists in an inactive form in the cytoplasm  complexed with heat shock protein 90 (hsp90). 2. Glucocorticoid (G) diffuses across cell membrane and enters cytoplasm 3. G binds to GR  changes conformation  dissociates from hsp90 4.  exposes a nuclear localization signal (stretch of aas) on GR. 5. G-GR (hormone-receptor complex, HR) enters nucleus, dimerizes with another HR.
  • 68. 6. HR dimer binds to enhancer/hormone-response element upstream of hormone activated gene. 7. Binding of HR dimer to enhancer  activates transcription. 8. Most contain 2 zinc fingers (1) controls DNA binding, (2) controls dimerization Critical residues for discriminating between GRE and ERE lie at the base of the first finger -GRE = glucocorticoid responsive element /enhancer (sequence); ERE = estrogen
  • 69. Specificity of DNA binding dimerization